XML 100 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table

Pay Versus Performance

 

The disclosure included in this section is prescribed by SEC rules and does not necessarily align with how our Company or the Compensation Committee view the link between Company performance and executive compensation for our principal executive officer (“PEO”) and our non-PEO NEOs. For additional information about our pay-for-performance philosophy and how we align executive compensation with Company performance, see our Compensation Discussion and Analysis beginning on page 82 of this proxy statement.

Required Tabular Disclosure of Pay Versus Performance

The amounts set forth below under the headings “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to Non-PEO NEOs” have been calculated in a manner consistent with Item 402(v) of Regulation S-K. Use of the term “compensation actually paid” is required by the SEC’s rules and, as a result of the calculation methodology required by the SEC, such amounts differ from compensation actually earned, realized or received by the individuals and the compensation decisions described in our Compensation Discussion and Analysis beginning on page 82 of this proxy statement.

 

 

 

Summary

 

 

Compensation

 

 

Average
Summary
Compensation

 

 

Average
Compensation
Actually

 

 

Value of Initial Fixed $
100 Investment Based on:
(3)

 

 

 

 

 

 

 

Year

 

Compensation
Table Total
for PEO
(1)
($)

 

 

Actually
Paid to
PEO
(1)(2)
($)

 

 

Table Total
for Non-PEO
NEOs
(1)
($)

 

 

Paid to
Non-PEO
NEOs
(1)(2)
($)

 

 

TSR
($)

 

 

Peer Group
TSR
($)

 

 

GAAP Net Income (Loss)
($ Millions)

 

 

Non-GAAP
Net Income
(4)
($ Millions)

 

(a)

 

(b)

 

 

(c)

 

 

(d)

 

 

(e)

 

 

(f)

 

 

(g)

 

 

(h)

 

 

(i)

 

2023

 

 

9,442,066

 

 

 

8,983,892

 

 

 

4,033,464

 

 

 

4,190,097

 

 

 

138.19

 

 

 

118.87

 

 

 

355.8

 

 

 

243.7

 

2022

 

 

10,314,172

 

 

 

8,321,591

 

 

 

4,155,421

 

 

 

4,206,760

 

 

 

128.09

 

 

 

113.65

 

 

 

(158.3

)

 

 

57.9

 

2021

 

 

8,846,588

 

 

 

11,225,263

 

 

 

2,942,671

 

 

 

2,882,217

 

 

 

114.02

 

 

 

126.45

 

 

 

(48.2

)

 

 

129.1

 

2020

 

 

8,041,702

 

 

 

6,883,292

 

 

 

2,882,616

 

 

 

2,656,656

 

 

 

97.79

 

 

 

126.42

 

 

 

(110.9

)

 

 

68.6

 

 

 

(1)
Richard F. Pops was our PEO for each year presented. The individuals comprising the non-PEO NEOs for each year presented are listed below.

 

2020

2021

2022

2023

James M. Frates

Iain M. Brown

Iain M. Brown

Iain M. Brown

David J. Gaffin

James M. Frates

David J. Gaffin

David J. Gaffin

Craig C. Hopkinson, M.D.

David J. Gaffin

Craig C. Hopkinson, M.D.

Craig C. Hopkinson, M.D.

Michael J. Landine

Craig C. Hopkinson, M.D.

Blair C. Jackson

Blair C. Jackson

Blair C. Jackson

 

 

 

(2)
For 2023, the amounts shown reflect the exclusion and inclusion of those certain amounts for the PEO and the non-PEO NEOs shown in the following tables. Equity values are calculated in accordance with ASC 718. Amounts shown in each of the Exclusion of Stock Awards and Option Awards columns are equal to the total amounts from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table on page 112 of this proxy statement. See the section entitled “Pay Versus Performance” on page 130 of the proxy statement for the 2023 Annual Meeting for the adjustments made to determine compensation actually paid amounts for prior years.

 

Year

 

Summary Compensation Table Total for PEO
($)

 

 

Exclusion of Stock Awards and Option Awards for PEO
($)

 

 

Inclusion of Equity Values for PEO
($)

 

 

Compensation Actually Paid to PEO
($)

 

2023

 

 

9,442,066

 

 

 

(6,831,832

)

 

 

6,373,658

 

 

 

8,983,892

 

 

Year

 

Average Summary Compensation Table Total for Non-PEO NEOs
($)

 

 

Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs
($)

 

 

Average Inclusion of Equity Values for Non-PEO NEOs
($)

 

 

Average Compensation Actually Paid to Non-PEO NEOs
($)

 

2023

 

 

4,033,464

 

 

 

(2,902,745

)

 

 

3,059,378

 

 

 

4,190,097

 

 

The amounts shown in the Inclusion of Equity Values column in each of the above tables are derived from the following amounts:

 

Year

 

Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO
($)

 

 

Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO
($)

 

 

Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO
($)

 

 

Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO
($)

 

 

Total - Inclusion of Equity Values for PEO
($)

 

2023

 

 

3,934,846

 

 

 

2,022,849

 

 

 

415,963

 

 

 

 

 

 

6,373,658

 

 

Year

 

Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs
($)

 

 

Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs
($)

 

 

Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs
($)

 

 

Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs
($)

 

 

Total - Average Inclusion of Equity Values for Non-PEO NEOs
($)

 

2023

 

 

2,453,179

 

 

 

437,482

 

 

 

168,717

 

 

 

 

 

 

3,059,378

 

 

(3)
The peer group TSR shown in this table utilizes the Nasdaq Biotechnology Index (also known as the IBB Index), which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report. The comparison assumes $100 was invested in the Company and in the Nasdaq Biotechnology Index, respectively, for the period starting December 31, 2019 through the end of the year shown. Historical share price performance is not necessarily indicative of future share price performance.

 

(4)
We determined non-GAAP net income to be the most important financial performance measure used to link Company performance to compensation actually paid to our PEO and non-PEO NEOs in 2023. This financial performance measure may not have been the most important financial performance measure for certain prior years shown and we may determine a different financial performance measure to be the most important financial performance measure in future years. See Appendix B for information regarding this non-GAAP financial measure.
     
Company Selected Measure Name Non-GAAP Net Income      
Named Executive Officers, Footnote
(1)
Richard F. Pops was our PEO for each year presented. The individuals comprising the non-PEO NEOs for each year presented are listed below.

 

2020

2021

2022

2023

James M. Frates

Iain M. Brown

Iain M. Brown

Iain M. Brown

David J. Gaffin

James M. Frates

David J. Gaffin

David J. Gaffin

Craig C. Hopkinson, M.D.

David J. Gaffin

Craig C. Hopkinson, M.D.

Craig C. Hopkinson, M.D.

Michael J. Landine

Craig C. Hopkinson, M.D.

Blair C. Jackson

Blair C. Jackson

Blair C. Jackson

 

 

     
Peer Group Issuers, Footnote
(3)
The peer group TSR shown in this table utilizes the Nasdaq Biotechnology Index (also known as the IBB Index), which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report. The comparison assumes $100 was invested in the Company and in the Nasdaq Biotechnology Index, respectively, for the period starting December 31, 2019 through the end of the year shown. Historical share price performance is not necessarily indicative of future share price performance.
     
PEO Total Compensation Amount $ 9,442,066 $ 10,314,172 $ 8,846,588 $ 8,041,702
PEO Actually Paid Compensation Amount $ 8,983,892 8,321,591 11,225,263 6,883,292
Adjustment To PEO Compensation, Footnote
(2)
For 2023, the amounts shown reflect the exclusion and inclusion of those certain amounts for the PEO and the non-PEO NEOs shown in the following tables. Equity values are calculated in accordance with ASC 718. Amounts shown in each of the Exclusion of Stock Awards and Option Awards columns are equal to the total amounts from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table on page 112 of this proxy statement. See the section entitled “Pay Versus Performance” on page 130 of the proxy statement for the 2023 Annual Meeting for the adjustments made to determine compensation actually paid amounts for prior years.

 

Year

 

Summary Compensation Table Total for PEO
($)

 

 

Exclusion of Stock Awards and Option Awards for PEO
($)

 

 

Inclusion of Equity Values for PEO
($)

 

 

Compensation Actually Paid to PEO
($)

 

2023

 

 

9,442,066

 

 

 

(6,831,832

)

 

 

6,373,658

 

 

 

8,983,892

 

The amounts shown in the Inclusion of Equity Values column in each of the above tables are derived from the following amounts:

 

Year

 

Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO
($)

 

 

Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO
($)

 

 

Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO
($)

 

 

Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO
($)

 

 

Total - Inclusion of Equity Values for PEO
($)

 

2023

 

 

3,934,846

 

 

 

2,022,849

 

 

 

415,963

 

 

 

 

 

 

6,373,658

 

     
Non-PEO NEO Average Total Compensation Amount $ 4,033,464 4,155,421 2,942,671 2,882,616
Non-PEO NEO Average Compensation Actually Paid Amount $ 4,190,097 4,206,760 2,882,217 2,656,656
Adjustment to Non-PEO NEO Compensation Footnote
(2)
For 2023, the amounts shown reflect the exclusion and inclusion of those certain amounts for the PEO and the non-PEO NEOs shown in the following tables. Equity values are calculated in accordance with ASC 718. Amounts shown in each of the Exclusion of Stock Awards and Option Awards columns are equal to the total amounts from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table on page 112 of this proxy statement. See the section entitled “Pay Versus Performance” on page 130 of the proxy statement for the 2023 Annual Meeting for the adjustments made to determine compensation actually paid amounts for prior years.

Year

 

Average Summary Compensation Table Total for Non-PEO NEOs
($)

 

 

Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs
($)

 

 

Average Inclusion of Equity Values for Non-PEO NEOs
($)

 

 

Average Compensation Actually Paid to Non-PEO NEOs
($)

 

2023

 

 

4,033,464

 

 

 

(2,902,745

)

 

 

3,059,378

 

 

 

4,190,097

 

Year

 

Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs
($)

 

 

Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs
($)

 

 

Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs
($)

 

 

Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs
($)

 

 

Total - Average Inclusion of Equity Values for Non-PEO NEOs
($)

 

2023

 

 

2,453,179

 

 

 

437,482

 

 

 

168,717

 

 

 

 

 

 

3,059,378

 

     
Compensation Actually Paid vs. Total Shareholder Return

img77518306_77.jpg 

     
Compensation Actually Paid vs. Net Income

img77518306_78.jpg 

     
Compensation Actually Paid vs. Company Selected Measure

img77518306_79.jpg 

     
Tabular List, Table

The most important financial performance measures used to link compensation actually paid to our NEOs for 2023 to Company performance are set forth below. For further information regarding these performance metrics and their function in our executive compensation program, see our Compensation Discussion and Analysis beginning on page 82 of this proxy statement.

 

Proprietary Product Net Sales

Relative Total Shareholder Return

Non-GAAP Net Income*

Non-GAAP Net Income* as a Percentage of Total Revenue

EBITDA* as a Percentage of Total Revenue

 

* See Appendix B for information regarding this non-GAAP financial target.

     
Total Shareholder Return Amount $ 138.19 128.09 114.02 97.79
Peer Group Total Shareholder Return Amount 118.87 113.65 126.45 126.42
Net Income (Loss) $ 355,800,000 $ (158,300,000) $ (48,200,000) $ (110,900,000)
Company Selected Measure Amount 243,700,000 57,900,000 129,100,000 68,600,000
PEO Name Richard F. Pops Richard F. Pops Richard F. Pops Richard F. Pops
Measure:: 1        
Pay vs Performance Disclosure        
Name Proprietary Product Net Sales      
Measure:: 2        
Pay vs Performance Disclosure        
Name Relative Total Shareholder Return      
Measure:: 3        
Pay vs Performance Disclosure        
Name Non-GAAP Net Income      
Non-GAAP Measure Description
(4)
We determined non-GAAP net income to be the most important financial performance measure used to link Company performance to compensation actually paid to our PEO and non-PEO NEOs in 2023. This financial performance measure may not have been the most important financial performance measure for certain prior years shown and we may determine a different financial performance measure to be the most important financial performance measure in future years. See Appendix B for information regarding this non-GAAP financial measure.
     
Measure:: 4        
Pay vs Performance Disclosure        
Name Non-GAAP Net Income* as a Percentage of Total Revenue      
Measure:: 5        
Pay vs Performance Disclosure        
Name EBITDA* as a Percentage of Total Revenue      
PEO | Exclusion of Stock Awards and Option Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (6,831,832)      
PEO | Yearend Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 3,934,846      
PEO | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,022,849      
PEO | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 415,963      
PEO | Inclusion of Equity Values [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 6,373,658      
Non-PEO NEO | Exclusion of Stock Awards and Option Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (2,902,745)      
Non-PEO NEO | Yearend Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,453,179      
Non-PEO NEO | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 437,482      
Non-PEO NEO | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 168,717      
Non-PEO NEO | Inclusion of Equity Values [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 3,059,378